StemCells to acquire subsidiaries, assets of U.K. biotech firm

03/2/2009 | American City Business Journals

London-based Stem Cell Sciences has agreed to sell its operating units and certain related assets to StemCells for about $715,000 in cash and 2.65 million shares of stock. The deal, which was cleared by both firms' boards of directors, covers stem cell technologies as well as expertise and infrastructure for cell-based assays used in treatment discovery and testing.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC